RBC Biotech Analyst Leo Timashev shares his take on the sector and discusses companies he covers that are in the news
He discusses Insmed, IDEAYA, Bicycle, Compass Pathways, Revolution Medicines, Cytokinetics, and CG Oncology
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.